Latest filing published 04 Jun 2026 for Biomarin Pharmaceutical INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Willard H. Dere (board member) discloses dealings in 4 companies, chiefly Biomarin Pharmaceutical Inc, Mersana Therapeutics, Inc. and Radius Health, Inc. In total, 15 filings cover trades dated from 25 May 2021 to 2 June 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 4 June 2026: a share grant, in Biomarin Pharmaceutical Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations